CG Oncology, Inc. Common stock (CGON) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 1.08M | 2.32M | 1.67M | 0 | 52K | 456K | 43K | 111K | 529K | 1K | 9K | 194K | 0 |
| Revenue Growth % | 1982.69% | 409.21% | 3774.42% | -100% | -90.17% | 45500% | 377.78% | - | 172.68% | - | - | - | - |
| Cost of Goods Sold | 2.96M | 2.91M | 1.58M | 0 | 0 | 0 | 0 | 0 | 4K | 4K | 11.73M | 7.84M | 4K |
| COGS % of Revenue | 273.5% | 125.5% | 94.66% | - | - | - | - | - | 0.76% | 400% | 130388.89% | 4042.27% | - |
| Gross Profit | -1.88M | -592K | 89K | 0 | 52K | 456K | 43K | 111K | 525K | -3K | -11.73M | -7.65M | -4K |
| Gross Margin % | -173.5% | -25.5% | 5.34% | - | 100% | 100% | 100% | 100% | 99.24% | -300% | -130288.89% | -3942.27% | - |
| Gross Profit Growth % | -3713.46% | -229.82% | 106.98% | -100% | -90.1% | 15300% | 100.37% | - | 106.86% | 25% | - | - | - |
| Operating Expenses | 64.51M | 48.11M | 51.22M | 48.74M | 42.26M | 38.51M | 28.34M | 25.96M | 22.99M | 18.93M | 2.32M | 2.07M | 9.31M |
| OpEx % of Revenue | 5956.6% | 2071.83% | 3074.31% | - | 81261.54% | 8444.08% | 65902.33% | 23390.99% | 4346.69% | 1892900% | 25744.44% | 1068.56% | - |
| Selling, General & Admin | 20.78M | 17.99M | 23.33M | 17.41M | 14.79M | 11.71M | 8.72M | 7.49M | 5.78M | 3.01M | 2.32M | 2.07M | 1.65M |
| SG&A % of Revenue | 1918.74% | 774.94% | 1400.6% | - | 28440.38% | 2566.89% | 20269.77% | 6751.35% | 1093.38% | 301400% | 25744.44% | 1068.56% | - |
| Research & Development | 43.73M | 29.96M | 27.88M | 31.33M | 27.47M | 26.8M | 19.62M | 18.47M | 17.21M | 15.91M | 11.73M | 7.84M | 7.66M |
| R&D % of Revenue | 4037.86% | 1290.22% | 1673.71% | - | 52821.15% | 5877.19% | 45632.56% | 16639.64% | 3253.31% | 1591500% | 130388.89% | 4042.27% | - |
| Other Operating Expenses | 0 | 155K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K | 13K |
| Operating Income | -66.39M | -48.7M | -51.13M | -48.74M | -42.2M | -38.05M | -28.3M | -25.85M | -22.47M | -18.93M | -14.04M | -9.72M | -9.31M |
| Operating Margin % | -6130.1% | -2097.33% | -3068.97% | - | -81161.54% | -8344.08% | -65802.33% | -23290.99% | -4247.45% | -1893200% | -156033.33% | -5010.82% | - |
| Operating Income Growth % | -57.3% | -27.99% | -80.7% | -88.53% | -87.83% | -100.98% | -101.49% | - | -131.14% | -103.24% | - | - | - |
| EBITDA | -65.55M | -47.85M | -50.71M | -48.59M | -42.18M | -38.08M | -28.27M | -25.85M | -22.46M | -18.93M | -14.04M | -9.72M | -9.31M |
| EBITDA Margin % | -6052.45% | -2060.77% | -3044% | - | -81115.38% | -8351.1% | -65753.49% | -23284.68% | -4246.69% | -1892800% | -155985.19% | -5008.76% | - |
| EBITDA Growth % | -55.4% | -25.66% | -79.36% | -87.98% | -87.76% | -101.19% | -101.4% | - | -131.19% | -103.29% | - | - | - |
| D&A (Non-Cash Add-back) | 841K | 849K | 416K | 156K | 24K | -32K | 21K | 7K | 4K | 4K | 4.33K | 4K | 4K |
| EBIT | -66.39M | -41.31M | -43.81M | -48.74M | -42.2M | -38.05M | -28.3M | -25.85M | -22.47M | -18.93M | -14.04M | -9.72M | -9.51M |
| Net Interest Income | 6.29M | 22.49M | 7.42M | 7.32M | 7.75M | 6.25M | 7.89M | 6.94M | 5.55M | 2.82M | 2.28M | 1.05M | 910K |
| Interest Income | 6.29M | 22.49M | 7.42M | 7.32M | 7.75M | 6.25M | 7.89M | 6.94M | 5.55M | 2.82M | 2.28M | 1.05M | 910K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 6.19M | 7.39M | 7.32M | 7.32M | 7.75M | 6.25M | 7.89M | 6.95M | 5.54M | 2.82M | 2.27M | 1.05M | 923K |
| Pretax Income | -60.2M | -41.31M | -43.81M | -41.43M | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.12M | -11.77M | -8.67M | -8.39M |
| Pretax Margin % | -5558.82% | -1779.03% | -2629.53% | - | -66253.85% | -6973.25% | -47453.49% | -17028.83% | -3200.76% | -1611600% | -130755.56% | -4467.53% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -60.2M | -41.31M | -43.81M | -41.43M | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.12M | -11.77M | -8.67M | -8.39M |
| Net Margin % | -5558.82% | -1779.03% | -2629.53% | - | -66253.85% | -6973.25% | -47453.49% | -17028.83% | -3200.76% | -1611600% | -130755.56% | -4467.53% | - |
| Net Income Growth % | -74.74% | -29.91% | -114.69% | -119.16% | -103.47% | -97.31% | -73.39% | - | -95.36% | -92.04% | - | - | - |
| Net Income (Continuing) | -60.2M | -41.31M | -43.81M | -41.43M | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.12M | -11.77M | -8.67M | -8.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.71 | -0.52 | -0.57 | -0.54 | -0.45 | -0.49 | -0.30 | -0.28 | -0.22 | -0.33 | -0.28 | -0.13 | -0.13 |
| EPS Growth % | -57.78% | -6.12% | -90% | -92.86% | -104.55% | -48.48% | -7.14% | - | -69.23% | -153.85% | - | - | - |
| EPS (Basic) | -0.71 | -0.52 | -0.57 | -0.54 | -0.45 | -0.49 | -0.30 | -0.28 | -0.25 | -0.33 | -0.28 | -0.13 | -0.13 |
| Diluted Shares Outstanding | 84.52M | 77.3M | 76.73M | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
| Basic Shares Outstanding | 84.52M | 77.3M | 76.73M | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - |